skinny.

Latest / The HemOnc Pulse

Discussing the Role of MRD in CLL With Talal Hilal, MD

Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.